Targets › CPS1
1 program from 1 company in 1 trial: 1 Phase 1; Metabolic and endocrine; next expected readout Sep 2028.
Involved in the urea cycle of ureotelic animals where the enzyme plays an important role in removing excess ammonia from the cell. (UniProt, P31327)
Open in Phaseline: the race on CPS1, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Rebecca Ahrens-Nicklas | LNP.UCD.ABE adenine base editor (ABE) delivered by lipid nanoparticle (LNP) for urea cycle disorder ge | CPS1, OTC, ASS1, ASL, ARG1 | Phase 1 | Urea Cycle Disorders | Sep 2028 |
Urea Cycle Disorders (1)
protein or peptide (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.